−0.53USD
−32.49 MUSD
8.23 MUSD
63.00 M
About Clearside Biomedical, Inc.
Sector
CEO
George M. Lasezkay
Headquarters
Alpharetta
Website
Employees (FY)
30
Founded
2011
ISIN
US1850631045
FIGI
BBG002D4D4X3
Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. Its pipeline include CLS-AX, Integrin Inhibitor, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CLSD is 1.26 USD — it has increased by 9.57% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Clearside Biomedical, Inc. stocks are traded under the ticker CLSD.
Clearside Biomedical, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Clearside Biomedical, Inc. has a max estimate of 8.00 USD and a min estimate of 4.00 USD.
CLSD earnings for the last quarter are −0.15 USD whereas the estimation was −0.16 USD which accounts for 3.54% surprise. Estimated earnings for the next quarter are −0.09 USD. See more details about Clearside Biomedical, Inc. earnings.
Clearside Biomedical, Inc. revenue for the last quarter amounts to 859.00 K USD despite the estimated figure of 166.67 K USD. In the next quarter revenue is expected to reach 4.43 M USD.
Yes, you can track Clearside Biomedical, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, CLSD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Clearside Biomedical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 30.00 employees. See our rating of the largest employees — is Clearside Biomedical, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Clearside Biomedical, Inc. EBITDA is −24.78 M USD, and current EBITDA margin is −301.20%. See more stats in Clearside Biomedical, Inc. financial statements.